Skip to pricing

For MD · DO · NP · PA

Prescribe peptides on today's rules — not last year's.

The operational reference and monthly regulatory feed for clinicians who prescribe compounded peptides. Point-of-care protocol cards, exact reconstitution math, and an FDA-status tracker that updates every month.

503A status shifts every quarter Built for prescribers, not biohackers.

The problem with a certificate

A one-time credential goes stale. The regulations don't wait.

The compounded-peptide landscape changed materially in April 2026 and shifts every quarter — bulks-list actions, PCAC dockets, shortage resolutions. A doctor prescribing off a six-month-old course is exposed. Staying current is the whole job.

Feb 2025
Semaglutide shortage resolved — 503A enforcement discretion ends.
Apr 15 2026
FDA removes 12 peptides from Category 2 of the 503A bulks list.
Jun 29 2026
Comment period closes on excluding GLP-1s from the 503B bulks list.
Jul 23–24 2026
PCAC reviews BPC-157, TB-500, MOTS-c, KPV & more.

Members get every one of these tracked the month it happens — with each peptide's current status spelled out. That feed is the membership.

See a full edition and get it in your inbox every month, no purchase required.

What's actually inside

Operational tools a prescriber uses chairside — not a video library.

01

13 goal-based protocol cards

Pull the card that matches the patient's goal and work it top to bottom: lanes, dose ladders, hard stops, reconstitution, monitoring. No competitor ships point-of-care cards.

02

The reconstitution math, done

Every product and bottle size pre-calculated — vial mg, BAC water, units to draw — plus an interactive calculator.

PeptideVialAdd250 mcg =
BPC-15710 mg2 mL5 units
Ipamorelin10 mg2 mL5 units
Tesamorelin10 mg2 mL5 units
03

Monthly Regulatory Currency Tracker

FDA 503A status, PCAC dockets, and each peptide's current compounding state — refreshed every month. The moat.

04

48-peptide operational atlas

One-sheets and a full operational reference for deeper per-peptide detail when a card isn't enough.

05

PPA-CPP certification

Earned through a graded capstone case scored on a published rubric — a credible signal, with honest limits stated plainly.

06

Peptide reactions — recognize, manage, refer

The adverse-reaction reference prescribers actually reach for: what's expected, what's a stop-now red flag, and when to refer out. Unlocks inside the Membership.

Where it fits

Keep your academic CME. This is the part it doesn't give you.

  PPA A4M / Empire SSRP
Point-of-care protocol cardsYes — 13NoNo
Reconstitution calculatorYesNoNo
Monthly regulatory currencyYes — monthlyStatic2-yr recert
Accredited CMENot yetYesNo
Prescriber-first scopeYesYesYes

We don't claim accredited CME we don't have. We claim the operational layer and the currency feed — the things the credentials leave on the table.

See the full side-by-side comparison, honestly →

Three clear doors

Own the education. Add the tools. Stay current.

Buy the course once and you keep it for life. Subscribe when you want the living tools that keep up with the FDA.

The Course

The full education — yours for life. Just the course, nothing else.

$499one-time
  • Six tracks: foundations → building your practice
  • 59 lessons, science to chairside protocols
  • PPA-CPP certification path (capstone case)
  • Protocol-card lessons inside the course
  • Practitioner community access
  • Lifetime access — one payment
Get the course — $499

Best if you want the education and the credential.

The Protocol Deck

The chairside card set as a download you own — without subscribing.

$199one-time
  • 48 peptides across 13 goal-based protocols — the full protocol-card PDF set
  • Dose ladders, hard stops, reconstitution per card
  • Keep it on your device, print it, use it chairside
  • Yours to keep — one payment
  • Included free inside the Membership
Get the deck — $199

Add-on for course buyers who want the PDFs.

Prices in USD. Checkout is secure. Questions about which fits your practice? See the FAQ →

Straight answers

What a skeptical prescriber asks first

Is this accredited CME?
No — and we won't claim it is. This is operational continuing education and a regulatory-currency feed. It complements academic CME (A4M, IPS, SSRP, Empire); it doesn't replace it. Pursue accredited CME through your board or those programs.
Can my license type actually prescribe peptides?
Authority varies by state and license. MD/DO generally can within scope; NP/PA authority varies and may require a collaborative agreement. The course covers this in depth, but verify your state board's scope before prescribing. This is education, not legal advice.
What's the difference between the $499 course and the $199/month?
The course is the education — buy it once, keep it for life. The membership is the living layer: the reconstitution calculator, the protocol deck, the reactions reference, and the monthly regulatory tracker that keeps you current as the FDA moves. Many prescribers buy the course and subscribe for the tools.
If I cancel the membership, do I lose the course?
No. Anything you purchased one-time — the course, or the deck — is yours to keep. Canceling the membership only stops the monthly tools: the calculator, the included deck download, and the monthly tracker.
Is any of this medical advice?
No. Every protocol is an adaptable template for a licensed prescriber. All prescribing, dosing, titration, monitoring, and discontinuation decisions belong to the treating clinician based on the individual patient, their labs, and informed consent.

Stay the prescriber who's current.

Own the education for $499. Add the tools and the monthly regulatory feed for $199/month.

Educational purpose only — not medical advice. Peptide Prescriber Academy is continuing education and an operational reference for licensed clinicians. The author is a health coach, not a physician. All prescribing, dosing, titration, monitoring, and discontinuation decisions belong to the licensed prescribing clinician based on the individual patient's history, examination, labs, and informed consent. Compounded-peptide regulatory status changed materially in April 2026 and continues to evolve; verify the current FDA 503A status of any agent before each prescription. The PPA-CPP certification signals course completion and is not a medical license, board certification, or accredited CME unless separately filed with your licensing board.